Answers are grounded in this paper and cite their sources.
Erdheim-Chester disease is a multi-system histiocyte disorder characterised by histological xanthogranulomatous inflammation. We report a 67-year-old man who had fatal multi-systemic Erdheim-Chester disease involvement, including retroperitoneal fibrosis, dilated cardiomyopathy and bone pain that was diagnosed late in its course and was refractory to interferon-alfa. A pathogenic BRAF(V600E) mutation, identified after death in this patient, provides insights into pathogenesis and opens potential lines of treatment.
No takes yet. Share an insight, caveat, or question.
Bosco et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: